Evogene (EVGN) Institutional Ownership $1.25 -0.04 (-3.33%) Closing price 04:00 PM EasternExtended Trading$1.25 +0.00 (+0.40%) As of 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Evogene (NASDAQ:EVGN)CurrentInstitutional OwnershipPercentage10.40%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$138.42KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$270.75K Get EVGN Insider Trade Alerts Want to know when executives and insiders are buying or selling Evogene stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data EVGN Institutional Buying and Selling by Quarter Evogene Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025 Jane Street Group LLC33,732$42K0.0%+58.0%0.629% 5/15/2025 Armistice Capital LLC316,024$395K0.0%+5.9%5.890% 2/17/2025 Citadel Advisors LLC15,891$30K0.0%N/A0.296% 2/14/2025 Jane Street Group LLC21,345$40K0.0%N/A0.397% 11/13/2024 BNP Paribas Financial Markets12,200$37K0.0%-87.8%0.227% 10/10/2024 Renaissance Investment Group LLC10,000$31K0.0%N/A0.024% 5/1/2024 BNP Paribas Financial Markets91,400$69K0.0%+30.8%0.222% 11/13/2023 Silverarc Capital Management LLC3,100,000$1.82M0.6%+3,000.0%7.521% 8/15/2023 Silverarc Capital Management LLC100,000$107K0.0%N/A0.243% 7/27/2023 Virtu Financial LLC27,333$29K0.0%N/A0.066% Get the Latest News and Ratings for EVGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter. 10/28/2022 Silverarc Capital Management LLC167,510$139K0.0%-17.2%0.407% 7/25/2022 Silverarc Capital Management LLC202,322$156K0.0%-31.6%0.786% 4/20/2022 Sigma Planning Corp31,410$41K0.0%+88.0%0.122% 2/1/2022Eidelman Virant Capital113,000$185K0.1%N/A0.439% 1/28/2022 ARK Investment Management LLC3,611,842$6.02M0.0%-10.4%14.027% 11/16/2021 Squarepoint Ops LLC45,299$120K0.0%-53.6%0.176% 11/16/2021Susquehanna International Group Ltd.42,546$113K0.0%+51.2%0.165% 11/12/2021 Renaissance Technologies LLC265,200$700K0.0%+176.8%1.030% 11/12/2021 Senvest Management LLC230,606$609K0.0%-49.4%0.896% 11/12/2021 Jump Financial LLC16,800$44K0.0%-71.4%0.065% 11/12/2021Vident Investment Advisory LLC47,160$125K0.0%N/A0.183% 11/3/2021 Crestwood Advisors Group LLC14,000$37K0.0%N/A0.054% 10/28/2021 Sigma Planning Corp20,110$53K0.0%-19.9%0.078% 10/20/2021 Csenge Advisory Group34,700$91K0.0%+20.9%0.135% 8/16/2021 Squarepoint Ops LLC97,592$334K0.0%-14.6%0.379% 8/16/2021 PDT Partners LLC166,217$568K0.0%-10.4%0.646% 8/16/2021 Cubist Systematic Strategies LLC16,633$57K0.0%-41.8%0.065% 8/16/2021 Occudo Quantitative Strategies LP27,481$94K0.0%N/A0.107% 8/16/2021 Morgan Stanley901,584$3.08M0.0%+15.8%3.501% 8/16/2021 Goldman Sachs Group Inc.36,873$126K0.0%-21.0%0.143% 8/13/2021 Renaissance Technologies LLC95,800$328K0.0%N/A0.372% 8/13/2021 Senvest Management LLC455,340$1.56M0.0%-38.6%1.768% 8/13/2021 Jump Financial LLC58,700$201K0.0%+6.5%0.228% 8/13/2021 LPL Financial LLC59,485$203K0.0%+21.7%0.231% 8/13/2021 Geode Capital Management LLC26,731$91K0.0%+40.9%0.104% 8/12/2021 XTX Topco Ltd21,169$72K0.0%N/A0.082% 8/12/2021 Dimensional Fund Advisors LP39,044$134K0.0%+75.4%0.152% 8/12/2021 JPMorgan Chase & Co.192,887$660K0.0%-3.6%0.749% 8/11/2021Susquehanna International Group Ltd.28,143$96K0.0%N/A0.109% 5/18/2021 Morgan Stanley778,430$3.92M0.0%+201.2%3.023% This is my Christian duty (Ad)“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.Watch Jim Rickards reveal the Old Testament Wealth Code(Data available from 1/1/2016 forward) EVGN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EVGN shares? During the previous two years, the following institutional investors and hedge funds held shares of Evogene shares: Silverarc Capital Management LLC ($1.82M), Armistice Capital LLC ($395K), Jane Street Group LLC ($42K), BNP Paribas Financial Markets ($37K), and Renaissance Investment Group LLC ($31K), Citadel Advisors LLC ($30K).Learn more on Evogene's institutional investors. What percentage of Evogene's stock is owned by institutional investors? 10.40% of Evogene's stock is owned by institutional investors. Learn more on EVGN's institutional investor holdings. Which institutional investors have been buying Evogene's stock? The following institutional investors have purchased Evogene's stock in the last 24 months: Silverarc Capital Management LLC ($3M), Jane Street Group LLC ($33.73K), BNP Paribas Financial Markets ($21.50K), Armistice Capital LLC ($17.74K), Citadel Advisors LLC ($15.89K), and Renaissance Investment Group LLC ($10K). How much institutional buying is happening at Evogene? Institutional investors have bought a total of 77,366 shares in the last 24 months. This purchase volume represents approximately $138.42K in transactions. Which of Evogene's major shareholders have been selling company stock? The following institutional investors have sold Evogene stock in the last 24 months: BNP Paribas Financial Markets ($88.19K). How much institutional selling is happening at Evogene? Institutional investors have sold a total of 88,191 shares in the last 24 months. This volume of shares sold represents approximately $270.75K in transactions. Related Companies CARM Institutional Ownership SNES Institutional Ownership SDST Institutional Ownership TOMZ Institutional Ownership BSLK Institutional Ownership TANH Institutional Ownership DNMR Institutional Ownership ICL Institutional Ownership PCTTU Institutional Ownership LIN Institutional Ownership This page (NASDAQ:EVGN) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evogene Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evogene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access